EP.12B.04 BMF Deficiency Leads to an Increase of Drug Tolerant Persister Cells in ALK-Positive Lung Cancer
Back to course
Pdf Summary
Asset Subtitle
Takahiro Utsumi
Meta Tag
Speaker Takahiro Utsumi
Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy
Keywords
Bcl-2 modifying factor
drug-tolerant persister cells
ALK-positive NSCLC
ALK-TKI resistance
CRISPR screening
apoptosis
BIM
MCL-1 inhibition
therapeutic target
targeted therapies
Powered By